Study finds early potential in GSK leukaemia drug

Study finds early potential in GSK leukaemia drug: In a study published in the journal Nature, scientists from the British drugmaker collaborating with the charity Cancer Research UK (CRUK) and Cellzome AG found that the experimental drug, called I-BET151, mimics a chemical tag which is key to ...